Linike Medical Group Ltd.
LNMG
$0.0061
$0.00011.67%
OTC PK
| 07/31/2014 | 04/30/2014 | 01/31/2014 | 10/31/2013 | 07/31/2013 | |
|---|---|---|---|---|---|
| Net Income | 54.39% | 40.31% | 83.78% | -281.07% | 22.36% |
| Total Depreciation and Amortization | -- | -- | -- | -100.00% | -80.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | -54.42% | 425.00% | -98.44% | 620.88% | -78.93% |
| Cash from Operations | -54.55% | 120.25% | -126.40% | 1,137.82% | -107.56% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | 61.04% | -124.60% | 2,745.45% | -90.09% | 2,675.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 90.91% | 15.38% | -533.33% | 133.33% | 87.67% |